{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:20:12Z","timestamp":1787908812808,"version":"build-2784847793"},"reference-count":49,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Psychiatry in Clinical Practice"],"published-print":{"date-parts":[[2026,7,3]]},"DOI":"10.1080\/13651501.2026.2661356","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:18:56Z","timestamp":1777306736000},"page":"290-298","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Clozapine underutilization in Saudi Arabia: insights from a national survey of psychiatrists and implications for clinical training and practice"],"prefix":"10.1080","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4888-3757","authenticated-orcid":false,"given":"Muath M.","family":"Alqarni","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Directorate of Health Affairs","place":["Taif, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5276-0373","authenticated-orcid":false,"given":"Ahad R.","family":"Almuallim","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, King Fahad Armed Forces Hospital","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin Y.","family":"Demiroz","sequence":"additional","affiliation":[{"name":"Mental Health Department, Neuroscience Center, King Abdullah Medical City","place":["Makkah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain","family":"Khrad","sequence":"additional","affiliation":[{"name":"Neuroscience Department, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]},{"name":"College of Medicine, Alfaisal University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozan","family":"Omdah","sequence":"additional","affiliation":[{"name":"Neuroscience Department, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]},{"name":"College of Medicine, Alfaisal University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanady","family":"Gouta","sequence":"additional","affiliation":[{"name":"Neuroscience Department, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]},{"name":"College of Medicine, Alfaisal University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5465-346X","authenticated-orcid":false,"given":"Ahmad S.","family":"Alzahrani","sequence":"additional","affiliation":[{"name":"Neuroscience Department, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]},{"name":"College of Medicine, Alfaisal University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"1","key":"e_1_3_4_2_1","first-page":"1","article-title":"Early use of clozapine for poorly responding first-episode psychosis","volume":"43","author":"Agid O.","year":"2023","unstructured":"Agid, O., Remington, G., Kapur, S., Arenovich, T., & Zipursky, R. B. (2023). Early use of clozapine for poorly responding first-episode psychosis. Journal of Clinical Psychopharmacology, 43(1), 1\u20139.","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"e_1_3_4_3_1","first-page":"333","article-title":"Under-prescription of clozapine in Arab countries: Barriers and perspectives","volume":"40","author":"Al-Habeeb A. A.","year":"2019","unstructured":"Al-Habeeb, A. A., Al-Zahrani, M. A., Al-Najjar, A. A., et al. (2019). Under-prescription of clozapine in Arab countries: Barriers and perspectives. Saudi Medical Journal, 40(4), 333\u2013340.","journal-title":"Saudi Medical Journal,"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2025.104717"},{"key":"e_1_3_4_5_1","first-page":"897","article-title":"Patterns of psychotropic medication use in outpatient psychiatry clinics in Saudi Arabia","volume":"12","author":"Alosaimi F. D.","year":"2016","unstructured":"Alosaimi, F. D., AlZahrani, A., Altuwirqi, A., et al. (2016). Patterns of psychotropic medication use in outpatient psychiatry clinics in Saudi Arabia. Neuropsychiatric Disease and Treatment, 12, 897\u2013903.","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12742"},{"key":"e_1_3_4_7_1","first-page":"228","article-title":"Variation in clozapine prescribing across countries: A systematic review","volume":"268","author":"Bawor M.","year":"2018","unstructured":"Bawor, M., Dennis, B. B., Anglin, R., et al. (2018). Variation in clozapine prescribing across countries: A systematic review. Psychiatry Research, 268, 228\u2013235.","journal-title":"Psychiatry Research,"},{"key":"e_1_3_4_8_1","first-page":"115132","article-title":"Mobile monitoring tools for clozapine adherence: A feasibility study","volume":"324","author":"Begg D.","year":"2023","unstructured":"Begg, D., et al. (2023). Mobile monitoring tools for clozapine adherence: A feasibility study. Psychiatry Research, 324, 115132.","journal-title":"Psychiatry Research,"},{"key":"e_1_3_4_9_1","first-page":"128","article-title":"Global perspectives on clozapine education and use: An integrative review","volume":"23","author":"Chan J. K. N.","year":"2023","unstructured":"Chan, J. K. N., et al. (2023). Global perspectives on clozapine education and use: An integrative review. BMC Psychiatry, 23, 128.","journal-title":"BMC Psychiatry,"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.0624"},{"issue":"1","key":"e_1_3_4_11_1","first-page":"183","article-title":"Simulation-based clozapine training improves prescribing confidence: A UK pilot","volume":"22","author":"Duncan J.","year":"2022","unstructured":"Duncan, J., & Taylor, D. (2022). Simulation-based clozapine training improves prescribing confidence: A UK pilot. BMC Medical Education, 22(1), 183.","journal-title":"BMC Medical Education,"},{"key":"e_1_3_4_12_1","first-page":"354","article-title":"Understanding hematological risk perception among psychiatrists prescribing clozapine","volume":"228","author":"Dutta S.","year":"2021","unstructured":"Dutta, S., et al. (2021). Understanding hematological risk perception among psychiatrists prescribing clozapine. Schizophrenia Research, 228, 354\u2013362.","journal-title":"Schizophrenia Research,"},{"issue":"1","key":"e_1_3_4_13_1","first-page":"18","article-title":"Patterns of clozapine use in Egyptian psychiatric hospitals","volume":"27","author":"El-Badawy A.","year":"2020","unstructured":"El-Badawy, A., El-Tarras, A., & Saeed, A. (2020). Patterns of clozapine use in Egyptian psychiatric hospitals. Middle East Current Psychiatry, 27(1), 18.","journal-title":"Middle East Current Psychiatry,"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2016.01.006"},{"issue":"2","key":"e_1_3_4_15_1","first-page":"135","article-title":"Management of clozapine treatment interruptions: A European consensus statement","volume":"147","author":"Fokas V.","year":"2023","unstructured":"Fokas, V., et al. (2023). Management of clozapine treatment interruptions: A European consensus statement. Acta Psychiatrica Scandinavica, 147(2), 135\u2013145.","journal-title":"Acta Psychiatrica Scandinavica,"},{"key":"e_1_3_4_16_1","first-page":"56","article-title":"Attitudes toward clozapine among outpatients with schizophrenia: The patient perspective","volume":"230","author":"Freudenreich O.","year":"2021","unstructured":"Freudenreich, O., Cather, C., Evins, A. E., Henderson, D. C., & Goff, D. C. (2021). Attitudes toward clozapine among outpatients with schizophrenia: The patient perspective. Schizophrenia Research, 230, 56\u201362.","journal-title":"Schizophrenia Research,"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12193"},{"issue":"1","key":"e_1_3_4_18_1","first-page":"e11","article-title":"International comparison of clozapine prescribing and monitoring","volume":"5","author":"Gee S.","year":"2019","unstructured":"Gee, S., Vergunst, F., Howes, O., et al. (2019). International comparison of clozapine prescribing and monitoring. British Journal of Psychiatry Open, 5(1), e11.","journal-title":"British Journal of Psychiatry Open,"},{"issue":"2","key":"e_1_3_4_19_1","first-page":"23m14827","article-title":"Clozapine utilization in the United States 2005\u20132022: Trends and determinants","volume":"84","author":"Gurrera R. J.","year":"2023","unstructured":"Gurrera, R. J., Perry, N. L., & Frankenburg, F. R. (2023). Clozapine utilization in the United States 2005\u20132022: Trends and determinants. Journal of Clinical Psychiatry, 84(2), 23m14827.","journal-title":"Journal of Clinical Psychiatry,"},{"issue":"2","key":"e_1_3_4_20_1","first-page":"77","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: Update 2020","volume":"21","author":"Hasan A.","year":"2020","unstructured":"Hasan, A., Falkai, P., Wobrock, T., et al. (2020). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: Update 2020. World Journal of Biological Psychiatry, 21(2), 77\u2013123.","journal-title":"World Journal of Biological Psychiatry"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2016.16050503"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.18com12123"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800330013001"},{"issue":"1","key":"e_1_3_4_24_1","first-page":"e21","article-title":"The European Psychiatric Association survey on clozapine training gaps","volume":"63","author":"Lally J.","year":"2020","unstructured":"Lally, J., et al. (2020). The European Psychiatric Association survey on clozapine training gaps. European Psychiatry, 63(1), e21.","journal-title":"European Psychiatry,"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S115741"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125319859961"},{"key":"e_1_3_4_27_1","first-page":"204512532110115","article-title":"Variations in clinical decision-making for clozapine reinitiation: A multicenter review","volume":"11","author":"Leung J. G.","year":"2021","unstructured":"Leung, J. G., et al. (2021). Variations in clinical decision-making for clozapine reinitiation: A multicenter review. Therapeutic Advances in Psychopharmacology, 11, 2045125321101151.","journal-title":"Therapeutic Advances in Psychopharmacology,"},{"issue":"3","key":"e_1_3_4_28_1","first-page":"215","article-title":"Infrastructure-related barriers to clozapine use in low- and middle-income countries","volume":"24","author":"Manu P.","year":"2020","unstructured":"Manu, P., Dima, L., & Correll, C. U. (2020). Infrastructure-related barriers to clozapine use in low- and middle-income countries. International Journal of Psychiatry in Clinical Practice, 24(3), 215\u2013223.","journal-title":"International Journal of Psychiatry in Clinical Practice,"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12445"},{"key":"e_1_3_4_30_1","first-page":"865235","article-title":"Advances in understanding and treating cognitive impairment in schizophrenia","volume":"13","author":"Murphy K. C.","year":"2022","unstructured":"Murphy, K. C., McMahon, R. P., Velligan, D. I., et al. (2022). Advances in understanding and treating cognitive impairment in schizophrenia. Frontiers in Psychiatry, 13, 865235.","journal-title":"Frontiers in Psychiatry"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12898"},{"issue":"6","key":"e_1_3_4_32_1","first-page":"520","article-title":"Clozapine prescribing practices in Asia: Findings from the REAP study","volume":"50","author":"Ng C. H.","year":"2016","unstructured":"Ng, C. H., Chong, S. A., Lambert, T., et al. (2016). Clozapine prescribing practices in Asia: Findings from the REAP study. Australian & New Zealand Journal of Psychiatry, 50(6), 520\u2013526.","journal-title":"Australian & New Zealand Journal of Psychiatry,"},{"issue":"8","key":"e_1_3_4_33_1","first-page":"879","article-title":"Clozapine barriers and facilitators across Europe: An updated review","volume":"35","author":"Nielsen J.","year":"2021","unstructured":"Nielsen, J., et al. (2021). Clozapine barriers and facilitators across Europe: An updated review. CNS Drugs, 35(8), 879\u2013891.","journal-title":"CNS Drugs,"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0311-1"},{"issue":"8","key":"e_1_3_4_35_1","first-page":"896","article-title":"Psychiatrists\u2019 attitude towards and knowledge of clozapine treatment","volume":"30","author":"Nielsen R. E.","year":"2016","unstructured":"Nielsen, R. E., Dahm, M., Lublin, H., & Taylor, D. (2016). Psychiatrists\u2019 attitude towards and knowledge of clozapine treatment. Journal of Psychopharmacology, 30(8), 896\u2013902.","journal-title":"Journal of Psychopharmacology"},{"issue":"3","key":"e_1_3_4_36_1","first-page":"207","article-title":"Clozapine prescribing and monitoring practices in Saudi Arabia: A cross-sectional survey","volume":"23","author":"Obeid O.","year":"2019","unstructured":"Obeid, O., Arabi, A., Al-Mutairi, H., et al. (2019). Clozapine prescribing and monitoring practices in Saudi Arabia: A cross-sectional survey. International Journal of Psychiatry in Clinical Practice, 23(3), 207\u2013213.","journal-title":"International Journal of Psychiatry in Clinical Practice,"},{"issue":"2","key":"e_1_3_4_37_1","first-page":"235","article-title":"Administrative burden and clozapine prescribing behavior: A multicountry analysis","volume":"49","author":"Okhuijsen-Pfeifer C.","year":"2023","unstructured":"Okhuijsen-Pfeifer, C., et al. (2023). Administrative burden and clozapine prescribing behavior: A multicountry analysis. Schizophrenia Bulletin, 49(2), 235\u2013243.","journal-title":"Schizophrenia Bulletin,"},{"key":"e_1_3_4_38_1","first-page":"888722","article-title":"Telepsychiatry-enabled clozapine clinics: A systematic review","volume":"13","author":"Patel K.","year":"2022","unstructured":"Patel, K., et al. (2022). Telepsychiatry-enabled clozapine clinics: A systematic review. Frontiers in Psychiatry, 13, 888722.","journal-title":"Frontiers in Psychiatry"},{"issue":"9","key":"e_1_3_4_39_1","first-page":"908","article-title":"Clozapine patient monitoring service outcomes after digitalization","volume":"71","author":"Rajagopal S.","year":"2020","unstructured":"Rajagopal, S., et al. (2020). Clozapine patient monitoring service outcomes after digitalization. Psychiatric Services, 71(9), 908\u2013916.","journal-title":"Psychiatric Services,"},{"issue":"4","key":"e_1_3_4_40_1","first-page":"180","article-title":"Differences in clozapine prescribing by level of experience among Japanese psychiatrists","volume":"77","author":"Saito E.","year":"2023","unstructured":"Saito, E., et al. (2023). Differences in clozapine prescribing by level of experience among Japanese psychiatrists. Psychiatry and Clinical Neurosciences, 77(4), 180\u2013189.","journal-title":"Psychiatry and Clinical Neurosciences,"},{"issue":"5","key":"e_1_3_4_41_1","first-page":"259","article-title":"Early non-response in schizophrenia: Prediction of long-term outcomes and implications for clozapine use","volume":"216","author":"Samara M. T.","year":"2020","unstructured":"Samara, M. T., Leucht, S., Leucht, C., et al. (2020). Early non-response in schizophrenia: Prediction of long-term outcomes and implications for clozapine use. British Journal of Psychiatry, 216(5), 259\u2013266.","journal-title":"British Journal of Psychiatry,"},{"issue":"4","key":"e_1_3_4_42_1","first-page":"331","article-title":"Clozapine in Australia: Real-world patterns and outcomes","volume":"56","author":"Siskind D.","year":"2022","unstructured":"Siskind, D., et al. (2022). Clozapine in Australia: Real-world patterns and outcomes. Australian & New Zealand Journal of Psychiatry, 56(4), 331\u2013339.","journal-title":"Australian & New Zealand Journal of Psychiatry,"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.200061"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.115.177261"},{"key":"e_1_3_4_45_1","first-page":"103032","article-title":"Underutilization of clozapine in Asia: A review of barriers and facilitators","volume":"70","author":"Suttajit S.","year":"2022","unstructured":"Suttajit, S., Pilakanta, S., Chumchai, P., et al. (2022). Underutilization of clozapine in Asia: A review of barriers and facilitators. Asian Journal of Psychiatry, 70, 103032.","journal-title":"Asian Journal of Psychiatry,"},{"issue":"6","key":"e_1_3_4_46_1","first-page":"707","article-title":"Nationwide initiatives increased clozapine use in Finland: A 20-year registry analysis","volume":"215","author":"Taipale H.","year":"2019","unstructured":"Taipale, H., et al. (2019). Nationwide initiatives increased clozapine use in Finland: A 20-year registry analysis. British Journal of Psychiatry, 215(6), 707\u2013713.","journal-title":"British Journal of Psychiatry,"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.1322"},{"key":"e_1_3_4_48_1","first-page":"204512532110159","article-title":"Pharmacist-led clozapine monitoring clinics: An implementation model","volume":"11","author":"Vasudev K.","year":"2021","unstructured":"Vasudev, K., & Thomas, M., et al. (2021). Pharmacist-led clozapine monitoring clinics: An implementation model. Therapeutic Advances in Psychopharmacology, 11, 2045125321101593.","journal-title":"Therapeutic Advances in Psychopharmacology,"},{"issue":"9","key":"e_1_3_4_49_1","first-page":"868","article-title":"The impact of national clozapine programs on access and outcomes in New Zealand","volume":"52","author":"Wheeler A. J.","year":"2018","unstructured":"Wheeler, A. J., et al. (2018). The impact of national clozapine programs on access and outcomes in New Zealand. Australian & New Zealand Journal of Psychiatry, 52(9), 868\u2013877.","journal-title":"Australian & New Zealand Journal of Psychiatry,"},{"issue":"2","key":"e_1_3_4_50_1","first-page":"e000594","article-title":"Improving the quality of clozapine services in the UK: Barriers and facilitators","volume":"8","author":"Whiskey, E., Dzahini, O., Ramsay, R., O\u2019Flynn, D., Mijovic, A., Gaughran, F., & Taylor, D.","year":"2019","unstructured":"Whiskey, E., Dzahini, O., Ramsay, R., O\u2019Flynn, D., Mijovic, A., Gaughran, F., & Taylor, D. (2019). Improving the quality of clozapine services in the UK: Barriers and facilitators. BMJ Open Quality, 8(2), e000594.","journal-title":"BMJ Open Quality,"}],"container-title":["International Journal of Psychiatry in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13651501.2026.2661356","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/13651501.2026.2661356","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13651501.2026.2661356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:44:27Z","timestamp":1787906667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13651501.2026.2661356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7,3]]}},"alternative-id":["10.1080\/13651501.2026.2661356"],"URL":"https:\/\/doi.org\/10.1080\/13651501.2026.2661356","relation":{},"ISSN":["1365-1501","1471-1788"],"issn-type":[{"value":"1365-1501","type":"print"},{"value":"1471-1788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijpc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijpc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}